PHARMACY

Forest files suit over generic versions of hypertension drug

BY Alaric DeArment

NEW YORK — Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

Forest and Johnson & Johnson subsidiary Janssen Pharmaceutica NV have sued Glenmark, Hetero USA, Torrent Pharmaceuticals and Watson Labs in response to their filing regulatory approval applications with the Food and Drug Administration for generic versions of Bystolic (nebivolol).

Specifically, Forest and Janssen allege that the filings infringe U.S. Patent No. 6,545,040, which is scheduled to expire in December 2021, according to the FDA.

 


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

H.D. Smith appoints Bill Williams as CFO

BY Alaric DeArment

SPRINGFIELD, Ill. — Pharmaceutical wholesaler H.D. Smith has appointed Bill Williams as CFO, the company said Wednesday.

Williams, who has worked at such companies as Kraft Foods, Allied Signal and Martin Brower Co., most recently worked as a partner in Tatum LLC’s Chicago office.

"Bill has brought perspective to this pharmaceutical wholesale enterprise that elevates our customer excellence and accelerates our growth plan," H.D. Smith chairman and CEO Dale Smith said. "Best practices shared from many Fortune 500 companies are quickly becoming part of our working culture, and Bill’s ideas and abilities are making a significant impact."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Staying seated could up diabetes risk for women, study finds

BY Allison Cerra

NEW YORK — Women that are seated for longer periods of time are more likely to develop diabetes when compared with men, according to a new study.

Researchers from the departments of health sciences and cardiovascular sciences at University of Leicester in England assessed more than 500 men and women that were 40 years old and the amount of time the subjects spent sitting over the course of one week. They found that women who spent the longest time sitting had higher levels of insulin, as well as higher amounts of C-reactive protein and chemicals released by fatty tissue in the abdomen, leptin and interleukin6, which indicate problematic inflammation, the researchers said. The association between sitting and diabetes was not found, however, among the male subjects in the study.

"This study provides important new evidence that higher levels of sitting time have a deleterious impact on insulin resistance and chronic low-grade inflammation in women but not men and that this effect is seen regardless of how much exercise is undertaken," lead study author Thomas Yates said. "This suggests that women who meet the national recommendations of 30 minutes of exercise a day may still be compromising their health if they are seated for the rest of the day. It therefore suggests that enabling women to spend less time sitting may be an important factor in preventing chronic disease."

The study, "Self-Reported Sitting Time and Markers of Inflammation, Insulin Resistance and Adiposity," appeared in the American Journal of Preventive Medicine.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES